Effect of IBD medications on COVID-19 outcomes: results from an international registry.

Ungaro RC, Brenner EJ, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD

Open source

DOI: 10.1136/gutjnl-2020-322539
Published: 2021 Apr
Container: Gut
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/gutjnl-2020-322539,
  title = {Effect of IBD medications on COVID-19 outcomes: results from an international registry.},
  author = {Ungaro RC and Brenner EJ and Gearry RB and Kaplan GG and Kissous-Hunt M and Lewis JD and Ng SC and Rahier JF and Reinisch W and Steinwurz F and Underwood FE and Zhang X and Colombel JF and Kappelman MD},
  year = {2021},
  journal = {Gut},
  doi = {10.1136/gutjnl-2020-322539},
  url = {https://doi.org/10.1136/gutjnl-2020-322539}
}

RIS

TY  - JOUR
TI  - Effect of IBD medications on COVID-19 outcomes: results from an international registry.
AU  - Ungaro RC
AU  - Brenner EJ
AU  - Gearry RB
AU  - Kaplan GG
AU  - Kissous-Hunt M
AU  - Lewis JD
AU  - Ng SC
AU  - Rahier JF
AU  - Reinisch W
AU  - Steinwurz F
AU  - Underwood FE
AU  - Zhang X
AU  - Colombel JF
AU  - Kappelman MD
PY  - 2021
JO  - Gut
DO  - 10.1136/gutjnl-2020-322539
UR  - https://doi.org/10.1136/gutjnl-2020-322539
ER  -

APA

RC, U., EJ, B., RB, G., GG, K., M, K., JD, L., SC, N., JF, R., W, R., F, S., FE, U., X, Z., JF, C., & MD, K. (2021). Effect of IBD medications on COVID-19 outcomes: results from an international registry.. Gut. https://doi.org/10.1136/gutjnl-2020-322539

Source records

pubmed · retrieved 2026-09-26T05:15:47.913Z